Skip to main content

Client News

VPM contributes to the successful licensure of the novel malaria vaccine R21/Matrix-MTM for first use in Ghana

10th May 2023

Andera Partners appoints Stefan Keitel Senior Advisor DACH region further strengthening its presence in the German, Austrian and Swiss private equity markets

10th May 2023

Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert

10th May 2023

ONWARD Announces Results of Annual General Meeting of Shareholders

8th May 2023

Abivax publishes Universal Registration Document 2023 “Document d’Enregistrement Universel”

4th May 2023

Upon FDA approval, Advanced Medical Balloons launches innovative hygh-tec catheter system for ICU stool drainage in U.S. market

4th May 2023

ONWARD Schedules Webcast to Provide First Quarter Business Update

3rd May 2023

Mainz Biomed Announces Addition of Eurofins GeLaMed to its Growing Network of Lab Partners

3rd May 2023

Medigene AG: Medigene AG reports financial results and business update for Q1 2023

3rd May 2023

Newron to present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)

3rd May 2023

Medigene AG: Medigene acquires worldwide, exclusive license of CD40L-CD28 Costimulatory Switch Receptor

2nd May 2023

Abivax: Publication of an expert article in JCC on obefazimod as promising therapeutic management option for UC patients

2nd May 2023

Newron announces Senior Management Team changes

2nd May 2023

Destiny Pharma and SporeGen® announce update from research collaboration under Innovate UK grant award to develop a biotherapeutic treatment (SPOR-COV®) for COVID-19 and Influenza

2nd May 2023

Mainz Biomed to Participate in Digestive Disease Week 2023

2nd May 2023

Rentschler Biopharma Receives Worcester Business Journal 2023 Manufacturing Excellence Award

27th April 2023

LEON sets up lab facilities at the Innovation and Start-Up Center for Biotechnology (IZB) in Munich

27th April 2023

Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany

27th April 2023

Mainz Biomed announces partnership with the Instituto de Microecologia to Expand ColoAlert® commercialization in Spain and Portugal

26th April 2023

Carbios becomes partner of the first closed-loop recycling system for PET cups and trays launched by CITEO

26th April 2023

Medigene AG: Medigene presents final Phase I data of TCR-T cell therapy MDG1011 in patients with high-risk blood cancers

24th April 2023

Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture

24th April 2023

Element Materials: bioMérieux and JMI Laboratories partner to fight antimicrobial resistance (AMR)

20th April 2023

Abivax reports 2022 financial results and operations update

19th April 2023

Newron announces AGM 2023 results

18th April 2023

Andera Partners co-leads a Series A extension round totalling € 47.75 million for radiopharmaceutical company Ariceum Therapeutics

18th April 2023

InflaRx announces closing of the full exercise of greenshoe option increasing the proceeds of the recently announced public offering of ordinary shares to US$46 million

18th April 2023

Abivax appoints Michael Ferguson as Chief Commercial Officer

18th April 2023

Medigene AG: New data presented at AACR shows enhanced T cell functionality of MDG1015 in solid tumors

18th April 2023

invIOs presents promising new clinical data in solid tumors from autologous cell therapy APN401 at AACR Annual Meeting 2023

18th April 2023

Carbios accelerates its enzyme optimization with screening capabilities for millions of enzymes in a day

18th April 2023

Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis

17th April 2023

InflaRx announces closing of $40 million public offering of ordinary shares

14th April 2023

Heidelberg Pharma AG: Interim management statement on the first three months of 2023

13th April 2023

Destiny Pharma: Audited results for the year ended 31 December 2022

13th April 2023